Literature DB >> 31382180

Infection with Herpes Simplex virus type 1 (HSV-1) and sleep: The dog that did not bark.

Kyrillos M Meshreky1, Joel Wood2, Kodavali V Chowdari2, Martica H Hall2, Kristine A Wilckens2, Robert Yolken3, Daniel J Buysse2, Vishwajit L Nimgaonkar4.   

Abstract

Persistent infection with Herpes Simplex viruses (HSV) and other brain infections is consistently associated with cognitive impairment. These infections can also affect sleep. Thus, sleep abnormalities could explain the cognitive dysfunction. We investigated the association between sleep variables and persistent HSV-1, HSV-2, cytomegalovirus (CMV) and Toxoplasma gondii (Tox) infections. Sleep data were collected from older adults with or without insomnia (N = 311, total); a subset completed polysomnographic and actigraphy studies (N = 145). No significant associations were found between the infections and insomnia or the remaining sleep variables following corrections for multiple comparisons. Sleep dysfunction is unlikely to explain the infection-related cognitive dysfunction.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HSV-1; Herpesvirus; Sleep

Mesh:

Substances:

Year:  2019        PMID: 31382180      PMCID: PMC7265549          DOI: 10.1016/j.psychres.2019.112502

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  51 in total

Review 1.  Cytokines and sleep.

Authors:  Mark R Opp
Journal:  Sleep Med Rev       Date:  2005-10       Impact factor: 11.609

2.  Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection.

Authors:  S E Norman; A D Chediak; C Freeman; M Kiel; A Mendez; R Duncan; J Simoneau; B Nolan
Journal:  Sleep       Date:  1992-04       Impact factor: 5.849

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

Review 4.  Sleep and emotional processing.

Authors:  Daniela Tempesta; Valentina Socci; Luigi De Gennaro; Michele Ferrara
Journal:  Sleep Med Rev       Date:  2017-12-22       Impact factor: 11.609

5.  Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey.

Authors:  Kara D Tarter; Amanda M Simanek; Jennifer B Dowd; Allison E Aiello
Journal:  J Infect Dis       Date:  2013-11-18       Impact factor: 5.226

6.  Changes in Cognitive Performance Are Associated with Changes in Sleep in Older Adults With Insomnia.

Authors:  Kristine A Wilckens; Martica H Hall; Robert D Nebes; Timothy H Monk; Daniel J Buysse
Journal:  Behav Sleep Med       Date:  2015-08-31       Impact factor: 2.964

7.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

8.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

9.  Financial strain is a significant correlate of sleep continuity disturbances in late-life.

Authors:  Martica Hall; Daniel J Buysse; Eric A Nofzinger; Charles F Reynolds; Wesley Thompson; Sati Mazumdar; Timothy H Monk
Journal:  Biol Psychol       Date:  2007-11-04       Impact factor: 3.251

10.  Association between exposure to HSV1 and cognitive functioning in a general population of adolescents. The TRAILS study.

Authors:  Iris Jonker; Hans C Klein; Hester E Duivis; Robert H Yolken; Judith G M Rosmalen; Robert A Schoevers
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

View more
  1 in total

1.  Toxoplasma gondii infection and insomnia: A case control seroprevalence study.

Authors:  Cosme Alvarado-Esquivel; Sergio Estrada-Martínez; Alma Rosa Pérez-Álamos; Agar Ramos-Nevárez; Karina Botello-Calderón; Ángel Osvaldo Alvarado-Félix; Raquel Vaquera-Enríquez; Gustavo Alexis Alvarado-Félix; Antonio Sifuentes-Álvarez; Carlos Alberto Guido-Arreola; Elizabeth Rábago-Sánchez; Leandro Saenz-Soto
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.